Oncological long-term outcome of whole gland HIFU and open radical prostatectomy: a comparative analysis

ConclusionsWhile whole gland HIFU offers a comparable long-term efficacy for low-risk patients, sufficient cancer control for high-risk patients is more than doubtful. For the subgroup of intermediate-risk patients, CSS rates seem to be comparable up to 10 years suggesting that HIFU may be an alternative for older patients, although a higher risk of salvage treatment should be expected.

http://link.springer.com/10.1007/s00345-018-2613-z

Source: World Journal of Urology - January 2, 2019 Category: Urology & Nephrology Source Type: research